期刊文献+

血栓抽吸导管在急性心肌梗死患者治疗中的临床应用 被引量:14

Clinical study on application of thrombus aspiration catheter in treatment of patients with acute myocardial infarction
下载PDF
导出
摘要 目的评估ZEEK血栓抽吸导管在急性心肌梗死患者治疗中的临床应用。方法将316例行急诊介入治疗的急性心肌梗死患者分为两组,其中使用ZEEK血栓抽吸导管127例患者作为ZEEK组,未使用ZEEK血栓抽吸导管189例患者作为对照组。观察无复流发生率、术后ST段下降率、住院病死率及左心室射血分数等。结果ZEEK组4例发生无复流,发生率为3.1%,住院期间无死亡。对照组189例中有18例发生无复流,发生率9.5%,死亡6例(3.2%)。两组患者的无复流发生率、ST段下降率、住院病死率及心功能均具有显著差异(P<0.05)。结论急性心肌梗死在急诊介入治疗中,应用ZEEK血栓抽吸导管可以降低无复流发生率和住院病死率。 Objective To evaluate the application of ZEEK thrombus aspiration catheter in treat-ment of acute myocardial infarction (AMI) patient. Methods 127 AMI patients were treated with PCI plus ZEEK thromus aspiration catheter(ZEEK group)and 189 AMI patients were treated only with PCI(control group). The regression rate of ST segment, left ventricular ejection fraction (LVEF),incidence of no-reflow and mortality were followed up after PCI during hospitalization. Results No-reflow occurred in 18 patients(9.5%)and 4 patients (3.1%) in the control group and ZEEK group respectively,and 6 death were encountered only in the control group. The differ- ence between the two groups was statistically significant( P〈0.05). Conclusion Transcatheter aspiration of coronary thromus using ZEEK thromus aspiration catheter followed by direct stenting is an effective method to decrease mortality and morbidity of no-fellow during emergency PCI in AMI patient.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2008年第2期106-108,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 心肌梗塞 冠状动脉血栓形成 抽吸 预后 myocardial infarction coronary thrombosis suction prognosis
  • 相关文献

参考文献11

  • 1王乐丰,张大鹏.急性心肌梗死急诊再灌注治疗后心肌组织无复流的防治[J].临床内科杂志,2007,24(1):11-13. 被引量:5
  • 2Resnic FS,Wainstein M,Lee MK,et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J, 2003,145 : 42- 46. 被引量:1
  • 3Hisashi U, Toshiaki K, Mitsunori I, et al. The distal protection during primary percutaneous coronary intervention alleviates the adverse effects of large thrombus burden on myocardial reperfusion. Circulation,2006,70:232-238. 被引量:1
  • 4Svilaas T,van der Horst IC, Zijlstra F, et al. Thrombus aspiration during percutaneous coronary intervention in Acute Myocardial Infarction Study (TAPAS) study design. Am Heart J ,2006,151 :5971-5977. 被引量:1
  • 5Reffelmann T, Kloner RA. The no-reflow phenomenon:a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol,2006,101:359-372. 被引量:1
  • 6Iwakura K,Ito H,Ikushima M,et al. Association between hy perglycemia and the no-fellow phenomenon in patients with a cute myocardial infarction. J Am Coll Cardiol, 2003,41: 127-132. 被引量:1
  • 7Grube E,Schofer J,Webb J,et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol, 2002,89 : 941-945. 被引量:1
  • 8Kloner RA, Dai Wangde. Glycoprotein Ⅱ b/ Ⅲ a inhibitors and no reflow. J Am Coll Cardiol,2004,43:284-286. 被引量:1
  • 9Baim DS,Wahr D,George B,et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 2002,105 : 1285-1290. 被引量:1
  • 10Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primary angioplasty: safety,feasibility,and impact on myocardial reperfusion. Circulation, 2003,108:171-176. 被引量:1

二级参考文献21

  • 1Kunichika H,Ben-Yehuda O,Lafitte S,et al.Effects of glycoprotein Ⅱb/Ⅲa inhibition on microvascular flow after coronary reperfusion.A quantitative myocardial contrast echocardiography study.J Am Coll Cardiol,2004,43:276-283. 被引量:1
  • 2Zeymer U,Schroder K,Wegscheider K,et al.ST resolution in a single electrocardiographic lead:a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction.Am Heart J,2005,149:91-97. 被引量:1
  • 3Greaves K,Dixon S R,Fejka M,et al.Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction.Heart,2003,89:139-144. 被引量:1
  • 4Antoniucoi D,Rodriguez A,Hempel A,et al.A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.J Am Coll Cardiol,2003,42:1879-1885. 被引量:1
  • 5Lee DP,Herity NA,Hiatt BL,et al.Adjunctive platelet glyooprotein Ⅱb/Ⅲa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes:results of the Tirofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial.Circulation,2003,107:1497-1501. 被引量:1
  • 6Leonardo Bolognese,Giovanni Falsini,Francesco Liistro,et al.Randomized Comparison of Upstream Tirofiban Versus Downstream High Bolus Dose Tirofiban or Abciximab on Tissue-Level Perfusion and Troponin Release in High-Risk Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions.The EVEREST Trial.J Am Coll Cardiol,2006,47:522-528. 被引量:1
  • 7Eve D.Aymong,Michael J.Curtis,Mostafa Youssef,et al.Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting.Circulation,2002,105:2981-2985. 被引量:1
  • 8Jochen W(o)hrle,Olaf C.Grebe,Thorsten Nusser,et al.Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary Angioplasty.Circulation,2003,107:1840-1843. 被引量:1
  • 9Teng-Yao YANG,Shi-Tai CHANG,Chang-Ming CHUNG,et al.Restoration of Normal Coronary Flow With Tirofiban by Intracoronary Administration for No-reflow Phenomenon After Stent Deployment.Int Heart J,2005,46:139-145. 被引量:1
  • 10Satoshi Ota,Hidee Nishikawa,Masaki Takeuchi,et al.Impact of Nicorandil to Prevent Repeffusion Injury in Patients With Acute Myocardial Infarction-Sigmart Multicenter Angioplasty Revascularization Trial(SMART).Circ J,2006,70:1099-1104. 被引量:1

共引文献4

同被引文献99

引证文献14

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部